Met Life Investment Management, LLC Voyager Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

  • $16.6 Billion
  • Q2 2024

A detailed history of Met Life Investment Management, LLC transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 27,035 shares of VYGR stock, worth $158,154. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,035
Previous 18,269 47.98%
Holding current value
$158,154
Previous $170,000 25.29%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$7.42 - $10.54 $65,043 - $92,393
8,766 Added 47.98%
27,035 $213,000
Q1 2024

May 14, 2024
BUY
$7.15 - $10.84 $130,623 - $198,035
18,269 New
18,269 $170,000
Q3 2023

May 09, 2024
BUY
$7.55 - $11.25 $126,998 - $189,236
16,821 New
16,821 $130,000
Q2 2023

Apr 29, 2024
BUY
$6.94 - $13.99 $116,737 - $235,325
16,821 New
16,821 $192,000
Q2 2023

Aug 10, 2023
BUY
$6.94 - $13.99 $116,737 - $235,325
16,821 New
16,821 $192,000
Q4 2020

Feb 16, 2021
SELL
$7.15 - $12.28 $76,140 - $130,769
-10,649 Closed
0 $0
Q3 2020

Jun 26, 2023
BUY
$10.01 - $13.75 $106,596 - $146,423
10,649 New
10,649 $113,000
Q2 2020

May 24, 2024
SELL
$8.05 - $14.21 $61,341 - $108,280
-7,620 Reduced 41.71%
10,649 $134 Million
Q2 2020

Jun 26, 2023
BUY
$8.05 - $14.21 $85,724 - $151,322
10,649 New
10,649 $134,000
Q1 2020

Jul 12, 2023
BUY
$6.8 - $14.66 $72,413 - $156,114
10,649 New
10,649 $97,000
Q4 2019

Jul 12, 2023
BUY
$12.82 - $16.85 $136,520 - $179,435
10,649 New
10,649 $148,000
Q3 2019

Jul 12, 2023
BUY
$16.31 - $28.29 $173,685 - $301,260
10,649 New
10,649 $183,000
Q2 2019

Jul 12, 2023
BUY
$19.18 - $27.88 $204,247 - $296,894
10,649 New
10,649 $289,000
Q1 2019

Jul 13, 2023
BUY
$8.0 - $19.66 $85,192 - $209,359
10,649 New
10,649 $203,000
Q4 2018

Jul 13, 2023
BUY
$8.59 - $18.05 $91,474 - $192,214
10,649 New
10,649 $100,000
Q4 2018

Mar 22, 2023
SELL
$8.59 - $18.05 $63,574 - $133,588
-7,401 Reduced 41.0%
10,649 $100,000
Q4 2018

Feb 14, 2019
SELL
$8.59 - $18.05 $63,574 - $133,588
-7,401 Reduced 41.0%
10,649 $100,000
Q3 2018

Jul 13, 2023
BUY
$17.11 - $21.74 $182,204 - $231,509
10,649 New
10,649 $201,000
Q3 2018

Mar 22, 2023
BUY
$17.11 - $21.74 $308,835 - $392,407
18,050 New
18,050 $341,000
Q3 2018

Nov 14, 2018
BUY
$17.11 - $21.74 $126,631 - $160,897
7,401 Added 69.5%
18,050 $342,000
Q2 2018

Aug 15, 2018
BUY
$16.76 - $23.92 $49,676 - $70,898
2,964 Added 38.57%
10,649 $208,000
Q4 2017

Feb 15, 2018
BUY
$12.26 - $25.88 $94,218 - $198,887
7,685
7,685 $128,000

Others Institutions Holding VYGR

# of Institutions
128
Shares Held
36.7M
Call Options Held
48K
Put Options Held
36.2K
View Full List

About Voyager Therapeutics, Inc.

VYGR Quotes by TradingView
  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $226M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email